they can be managed by either lowering your dosage or escalating it at a slower pace
When analyzing serum TG levels, we found that semaglutide had a tendency to lower TGs, whereas resmetirom was able to do so significantly (Figure H)
Reported Side Effects by Dose Level Most gastrointestinal side effects were mild to moderate and occurred primarily during dose escalation
The secondary outcomes were improvement in the components of metabolic syndrome, lipid panel (total cholesterol, triglyceride, high-density lipoprotein, and low-density lipoprotein), hepatic panel (albumin, total protein, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase), and adiposity, oxidative stress, and inflammation biomarkers
Note: Never use plain sterile water or tap water for medication meant for multi-dose use